Latest Corporate News News
Omnicom completes $13.5B acquisition of Interpublic Group
Omnicom finalized its $13.5 billion purchase of rival Interpublic Group, creating the largest advertising holding company and reshaping industry scale and tech capabilities, a deal analysts say will accelerate consolidation in ad tech and data services.
Pfizer–Novo Nordisk bidding war and Metsera acquisition fallout
Pfizer led a high‑profile bidding contest for obesity biotech Metsera, ending with Pfizer's takeover attempts that underscored intense pharma competition in GLP‑1 and obesity therapeutics and triggered further sector consolidation.
Markets move after U.S. order blocking oil tankers to Venezuela
Global markets and oil prices reacted strongly after a U.S. blockade order on tankers to Venezuela, lifting energy stocks and nudging global indices amid commodity supply concerns.
Nomura lists new EURO STOXX 50 and DAX‑tracking ETFs on TSE
Nomura Asset Management launched ETFs designed to track the EURO STOXX 50® JPY TTM and DAX® JPY TTM on the Tokyo Stock Exchange, expanding European equity access for Japanese investors.
Johnson & Johnson leads one of 2025’s biggest biopharma deals
A wave of major biopharma M&A in 2025 included Johnson & Johnson's $14.6 billion transaction and other transformative deals that reshaped vaccine, obesity, and cell‑therapy strategies across the sector.
HEICO acquires electric power generation component repair firms
HEICO Corporation announced acquisitions of leading repair companies in electric power generation to expand its presence in the aeroderivative industrial gas turbine market and support global aftermarket growth.
Kirkland advises A&M on acquisition of Asurint
Kirkland & Ellis reported advising Alvarez & Marsal in its announced acquisition of background‑screening firm Asurint, a transaction that included Guidepost Growth Equity’s exit and strategic consolidation in HR services.
2025 marks a landmark year for ad and media M&A
Media and advertising saw historic dealmaking throughout 2025, with mega‑mergers and buyouts driven by scale needs for AI and data capabilities, signaling continued industry consolidation.
Seven most impactful biopharma deals of 2025 highlighted
Industry analyses ranked seven M&A transactions as most impactful in biopharma for 2025, noting competition over obesity biotech, cell therapy acquisitions, and portfolio reshaping among Big Pharma.
Global markets digest mixed U.S. jobs data alongside commodity moves
Markets reacted to mixed U.S. employment reports that left Fed policy expectations unsettled, while energy and commodities moved on geopolitical developments, influencing equities and futures globally.